Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Development of novel Asf1-H3/H4 inhibitors.

Miknis GF, Stevens SJ, Smith LE, Ostrov DA, Churchill ME.

Bioorg Med Chem Lett. 2015 Feb 15;25(4):963-8. doi: 10.1016/j.bmcl.2014.11.067. Epub 2014 Dec 4.

2.

Non-oxime inhibitors of B-Raf(V600E) kinase.

Ren L, Wenglowsky S, Miknis G, Rast B, Buckmelter AJ, Ely RJ, Schlachter S, Laird ER, Randolph N, Callejo M, Martinson M, Galbraith S, Brandhuber BJ, Vigers G, Morales T, Voegtli WC, Lyssikatos J.

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1243-7. doi: 10.1016/j.bmcl.2010.12.061. Epub 2010 Dec 19.

PMID:
21251822
3.

The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors.

Buckmelter AJ, Ren L, Laird ER, Rast B, Miknis G, Wenglowsky S, Schlachter S, Welch M, Tarlton E, Grina J, Lyssikatos J, Brandhuber BJ, Morales T, Randolph N, Vigers G, Martinson M, Callejo M.

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1248-52. doi: 10.1016/j.bmcl.2010.12.039. Epub 2010 Dec 10.

PMID:
21211972
4.

NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.

Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW.

J Med Chem. 1997 Sep 26;40(20):3144-50.

PMID:
9379433
5.

Liquid chromatography of lanthanide chelates of 1-(p-nitrophenyl)ethylenediamine-N,N,N',N' -tetra-acetic acid.

Mulero O, Nelson DA, Archer VS, Miknis G, Beckett JR, McLean HL.

Talanta. 1990 Apr;37(4):381-4.

PMID:
18964955

Supplemental Content

Loading ...
Support Center